Sarepta provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote the highest standards of care, raise awareness of ongoing research, or focus on other critical community initiatives.
Requests will be considered across the spectrum of neuromuscular and rare diseases, with priority assigned to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other disease areas of focus for the company. Applications are accepted on a rolling basis and are generally reviewed monthly by the committee. Our team will review your request and contact you within 90 days of your submission. Requests considered may include those that support:
the communities Sarepta serves globally
programs and activities that seek to advance medical and disease education, and that address the unmet needs of patients
charitable causes and events that are of importance to the communities we serve
collaborative learning experiences through engagement with various stakeholders from the Duchenne community
programs that target a broad population of patients
Requests that typically cannot be supported may include:
funds that will benefit an individual or specific subset of the disease community
proposals for support of general education or programs if one of Sarepta’s disease areas of focus are not highlighted
programs that duplicate efforts that are actively ongoing in the community or that Sarepta has already supported